Document Detail


Tall stature in familial glucocorticoid deficiency.
MedLine Citation:
PMID:  11012566     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Familial glucocorticoid deficiency (FGD) has frequently been associated with tall stature in affected individuals. The clinical, biochemical and genetic features of five such patients were studied with the aim of clarifying the underlying mechanisms of excessive growth in these patients. PATIENTS AND METHODS: Five patients with a clinical diagnosis of FGD are described in whom the disorder resulted from a variety of novel or previously described missense or nonsense mutations of the ACTH receptor (MC2-R). All patients demonstrated excessive linear growth over that predicted from parental indices and increased head circumference. RESULTS: Growth hormone and IGF-I-values were normal. Growth charts suggest that the excessive growth is reduced to normal following the introduction of glucocorticoid replacement. A characteristic facial appearance including hypertelorism, marked epicanthic folds and prominent frontal bossing was noted. CONCLUSIONS: These findings indicate that ACTH resistance resulting from a defective ACTH receptor may be associated with abnormalities of cartilage and/or bone growth independently of the GH-IGF-I axis, but probably dependent on ACTH actions through other melanocortin receptors.
Authors:
L L Elias; A Huebner; L A Metherell; A Canas; G L Warne; M L Bitti; S Cianfarani; P E Clayton; M O Savage; A J Clark
Related Documents :
15198296 - Asymptomatic testicular adrenal rest tumours in adolescent and adult males with congeni...
9367326 - Mr findings in hereditary isolated growth hormone deficiency.
20501686 - Predictive role of the immunostaining pattern of immunofluorescence and the titers of a...
16472586 - Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytok...
7953506 - Transjugular intrahepatic portosystemic stent-shunt (tipss): long-term follow-up.
4030146 - Effects of pharmacologic autonomic blockade on atrial electrophysiologic properties in ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical endocrinology     Volume:  53     ISSN:  0300-0664     ISO Abbreviation:  Clin. Endocrinol. (Oxf)     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-11-09     Completed Date:  2000-11-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  423-30     Citation Subset:  IM    
Affiliation:
Department of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenocorticotropic Hormone / blood
Age Determination by Skeleton
Body Height*
Child
Child, Preschool
Glucocorticoids / deficiency*
Growth Disorders / drug therapy,  genetics*
Humans
Hydrocortisone / blood,  therapeutic use
Infant
Infant, Newborn
Male
Microsatellite Repeats
Mutation, Missense
Sequence Analysis, DNA
Chemical
Reg. No./Substance:
0/Glucocorticoids; 50-23-7/Hydrocortisone; 9002-60-2/Adrenocorticotropic Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterization of a novel DNA polymorphism in the human CYP21 gene and application for DNA diagnos...
Next Document:  Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 we...